With a lightweight design, AMOLED display, and full health tracking suite, it could become an appealing alternative to ...

If you’ve been thinking about upgrading from a basic tracker to a “real” fitness smartwatch, this is a good moment. The ...

TEMPO.CO, Jakarta - For the first time in 14 years, Apple is projected to overtake Samsung as the leader in the global smartphone market, driven by the success of the new iPhone series. Counterpoint ...

India has set a 90-day deadline for smartphone manufacturers, including Apple, to integrate the Sanchar Saathi app into their ...

A U.S. jury ruled on November 15, 2025, that Apple must pay Masimo $634 million in a patent infringement case over smartwatch technology, awarding Masimo a major victory after years of litigation.

What just happened? Apple has been dealt a blow in its long-running patent battle against Masimo after a court ordered Cupertino to pay the health tech firm $634 million. The decision came on the same ...

A federal jury in the U.S. District Court for the Central District of California has ruled that Apple must pay $634 million to Masimo for allegedly infringing on a patent covering ‌blood-oxygen ...

Amid its multifront legal battle with Apple over its smartwatch’s blood oxygen sensors, Masimo has claimed new ground—including a significant patent infringement verdict in federal court, plus the ...

Masimo Corp. announced that it won a $634 million verdict against Apple Inc. last Friday. A California federal jury sided with the Irvine-based medical device maker, finding that Apple’s watches ...

A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...

Apple plans to appeal the verdict, a spokesperson told news outlets. A federal jury in California has decided that Apple owes medtech company Masimo $634m for infringing on its patented blood-oxygen ...

Additionally, Masimo’s revenue reached $371.5 million, slightly higher than the anticipated $366.85 million. These figures highlight the company’s strong financial performance during this period.